drugset / Trial / NCT07187466
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
RandomizedSequentialSingle-blindTreatment
Summary
The purpose of this study is to learn about different treatments for overactive bladder symptoms in Parkinson's Disease. The investigators want to find out if people who do not respond to one treatment (either behavioral or drug treatment) will respond to combined treatment. The investigators also want to find out what factors influence whether someone responds to the treatments.
Timeline
- Start
- 2026-07-01
- Primary completion
- 2030-03-31
- Completion
- 2030-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mirabegron | Other / unclassified | 25 mg | — |